| Literature DB >> 34978891 |
Dan Smelter1, Mary Hayney1, George Sakoulas2, Warren Rose1.
Abstract
Cefazolin and ertapenem have been shown to be an effective salvage regimen for refractory methicillin-susceptible Staphylococcus aureus bacteremia. Our findings suggest cefazolin plus ertapenem in vitro stimulates interleukin-1β release from peripheral blood monocytes both with and without S. aureus presence. This IL-1β augmentation was primarily driven by ertapenem. These findings support further exploration of cefazolin plus ertapenem in MSSA bacteremia and may partially explain its marked potency in vivo despite modest synergy in vitro.Entities:
Keywords: antimicrobial combinations; beta-lactams; immunology; in vitro; innate immunity
Mesh:
Substances:
Year: 2022 PMID: 34978891 PMCID: PMC8846438 DOI: 10.1128/aac.02166-21
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.938